chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Brain fog; my BP was low; This is a spontaneous report from a contactable consumer. This 39-year-old male consumer (patient) reported in response to Non-HCP follow-up letter sent in cross reference case. A 39-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL3246) via intramuscular, administered in Arm Right on 23Jan2021 18:00 (at the age of 39-year-old) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included GERD from 2000 and ongoing LINX implant (surgery) 2018 , ongoing Ineffective esophageal motility disorder , ongoing small fiber neuropathy, ongoing Dysautonomia , ongoing migraine, vestibular migraine from an unknown date and unknown if ongoing Hypertension, Vestibular migraine-mother , ongoing vasovagal syncope, ongoing hypotension , High Cholesterol from an unknown date and unknown if ongoing High Cholesterol-Father , hypertension from an unknown date and unknown if ongoing Hypertension, Vestibular migraine-mother. Concomitant medication(s) included nadolol taken for presyncope, autonomic nervous system imbalance from an unspecified start date and ongoing; midodrine taken for hypotension, presyncope from an unspecified start date and ongoing; esomeprazole magnesium taken for gastrooesophageal reflux disease, oesophageal motility disorder from an unspecified start date and ongoing; amitriptyline taken for oesophageal motility disorder from an unspecified start date and ongoing; docusate sodium; azelastine; mometasone furoate (NASONEX); cetirizine; fluocinonide; magnesium oxide; cyanocobalamin (VIT B12); ciclosporin (RESTASIS); sodium alginate; naproxen sodium (ALEVE) all these taken for an unspecified indication, start and stop date were not reported. Prior Vaccinations was reported as none. Patient reported that, 2 days after 1st vaccine (on 25Jan2021), he had pretty severe brain fog. He thought it might be blood pressure related and his BP was low (89/55), but this was not entirely atypical for him. Brain fog persisted for about 5 days and thus lift. Reaction to second dose was Standard-Flu-like symptom of about a day or two then he was fine. The patient underwent lab tests and procedures which included biopsy skin: small fiber neuropathy on 05Jan2016 Results suggestive of a small fiber neuropathy, blood pressure measurement: 89/55 on an unspecified date low, tilt table test: unknown results on 09Jan2016 Abnormal Hemodynamic response to head up tilt, consistent with neurocardiogens-reflex mediated (vasovagal) syncope. The patient did not receive treatment for the resulted events. The clinical outcome of event brain fog was recovered on 30Jan2021, whereas event BP was low was unknown. No follow-up attempts are possible. No further information is expected.
Information has been received from a physician concerning an approximately 72 year old consumer with a history of having chickenpox twice, who on an unspecified date was vaccinated SQ with 0.65ml of zoster vaccine live (Oka/Merck). Subsequently a year after receiving the vaccination the patient developed a mild case of shingles. Medical attention was sought in the office. It was unspecified if lab studies were performed. At the time of the report the patient's status was unknown. There was no product complaint involved. Additional information has been requested.
1. Tongue Pappilitis - within 24 hours of the vaccine, the tip of my tongue or approximately 1/3 of the tongue was swollen, red with the the papilla tiny red dots.  Additionally, some of them were swollen and white.  It looks exactly like the photos of covid tongue.   2. Fibromyalgia Flare - About 8 hours after the initial expected vaccine reactions wore off, I experienced an extreme fibromyalgia flare consisting of pain in my legs of an intensity that I have not experienced in over a decade.  This lasted for 4-5 days and is only now just abating on day 6.
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with a dose of GARDASIL 9, administered by intramuscular route (strength, dose, anatomical location, lot # and expiration date were not provided), for prophylaxis. It was reported that the patient went to the pharmacist's facility to receive the second dose of GARDASIL 9, and an unspecified time period between doses that was longer than recommended in the prescribing information had elapsed since the initial dose. No adverse effects have been reported.
Information has been received from a health professional concerning a pt who was vaccinated with the first and second dose of varicella vaccine. Subsequently, a titer was drawn several weeks after the second dose and the pt had not converted. The pt was vaccinated with another series of varicella vaccine. Subsequently, another titer was drawn a few weeks after the second series, and the pt was seronegative. Additional info has been requested.
Started in left arm shooting pain, to the point where she couldn't pick up arm, then moved into neck.  Pain kept traveling up to jaw,  under eye and above left eye, including ear.  Pain sometimes goes to back.  Pt thought she was having a stroke and could barely talk.  Pt went to ER on 8/12, all labs came back perfect.  Was treated for muscles being inflammed,  pt is recommeded to follow up with PCP, pt is to be treated with steroids.
admit 2/18, vaccine 1/9, 2/3. PNA, COVID+. Treated w/zinc, dexa, abx. DCd to home.
After leaving the doctor's office approximately ten minutes after receiving the vaccines, patient developed a systemic allergic reaction for which we immediately returned to the doctor's office under an emergency situation. Symptoms included rapidly growing hives (urticaria) starting on neck spreading to face, arms, and legs; widespread redness; severe itching; and puffiness/swelling of cheek and under eye. Patient received BENADRYL and prednisone on site and prescribed to continue same for five days. Hives returned mildly the following day.
After 2nd dose on 3/26/20 blisters on right hand within 4 hours, dizzy and nauseous next day and still on day 5, feeling faint and hives all over body on day 5
Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced DIZZINESS (Dizziness). At the time of the report, DIZZINESS (Dizziness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided
She had all 4 shots so far and had 1 mild case of covid; She had all 4 shots so far and had 1 mild case of covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. An 83-year-old patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "She had all 4 shots so far and had 1 mild case of covid". Patient called in with questions about a letter the patient received from the program informing the patient their HCP state license number was missing for their enrolment in the program. When asked by the call agent to confirm the name of the medication the patient was calling about. The patient stated. Tikosyn 125mg. Patient later stated the following about the Pfizer-BioNTech COVID-19 Vaccine. Tell she has been very grateful for all their vaccines they helped keep her going through all this crazy stuff, she has had all 4 shots so far and had 1 mild case of covid.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Flu shot administered 10-6-22 at 1pm at place of work. Immediate intense pain in shoulder/arm. I hollered out ? ouch that hurt really bad?. The nurse said ?why are you hollering? Your the only one who has said it hurt.? Pain was sharp and my arm was very sore and weak all day . Took 2 Tylenol (no relief). Numbness/tingling down inner left arm to elbow and outside of hand and 2 fingers that started about 6 pm.  Cried all night with pain(no sleep) . Went to work 10-7-22  and told a RN what was happy to me from the shot. I also spoke with a Doctor of the practice. They recommended to take NSAIDS over the weekend and see how it is by Monday. Came home in tears with pain from tingling. Took a prescribed  muscle relaxer(for right shoulder injury) to help with flu shot side effects. By 4 pm I had tingling pain down my inner legs into feet on both sides. Rubbed Volteran cream on my shoulder , neck, and legs. Did not feel like being active at home, slept a bit but woke up in tears from the tingling electrical feeling all over my body.
Redness and warmth x 2 days. No pain, no fluctuance, no induration. Warm compress, loratadine, ibuprofen prn. F/U in 2 days.
Onset of fever (101.8), chills, body aches, and fatigue approximately 20-22 hours after dose was given.
Information has been received from the patient's father reporting on his 2 year old daughter. It was reported that the patient did not have concomitant medications, drug reactions, allergies or any pertinent medical history. In late February 2017 the patient was vaccinated with M-M-R II for prophylaxis (route of administration, lot number, expiration date, dose and dose number were not provided). On an unknown date the patient experienced a fever that went away within 24 hours. The patient's father also reported that he learned that the vaccine administered in February 2017 had been expired for eight months at the time of administration. At the time of the reporting the outcome of fever was reported as resolved. The causal relationship between the adverse event and the therapy with M-M-R II was not provided. Additional information has been requested.
Mom reports patient became ill during noc with 100 degree temp.  Stomach, emesis with yellow bile & yellow skin, loose stool.  Continues with above c/o this morning.  Referred to MD.
Patient received administration of expired varicella vaccine. No treatment was performed, incident was discovered 2/26/2021. Patient has been contacted and denied any signs or symptoms of any adverse reaction.
Adult dose of Pneumococcal (Pneumovax) vaccine given. Was told by CDC of appropriate actions including reporting to this website.
On 1/17/03, vomiting and diarrhea X 24 hours. On 1/18/03, 102.5F-103F fever X 2 days. On 1/19/03, rash-erythema ?
pt recvd 3 doses of Engerix-B 21NOV90, 21DEC90, & 6JUN91; 29JUL91 lab test indicated did not convert; recvd a booster dose of Engerix-B 5AUG91; 23SEP91 lab tests indicated pt did not convert;
Pt recv vax on 2/12/98; 1 hr post vax pt exp backache
10 min after shot experience, throat irritation, asked for BENADRYL, 15 min later, throat sore and tongue feeling like jello, problem breathing administered EPIPEN 0.3mg. Called 911. Paramedics came gave epi and SOLU-MEDROL took to hospital.
Pt recvd vax & exp lightheadedness, ataxia, h/a;
Patient had a large painful bump and rash underneath her arm on the side of her thorax. Patient began feeling the pain a few hours after the vaccine and by Saturday (5/19/18) it had progressed and become larger and more painful. Patient came in on Monday (5/21/18) to report the adverse effect and to pick up a prescription for Cephalexin for it.
Patient received an expired dose; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 5-year-old male patient who received DTPa-IPV (Kinrix) (batch number D24G7, expiry date 4th June 2022) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 23rd June 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 23rd June 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 23-JUN-2022 Reporter's comments:  The patient received an expired dose of Kinrix, the vaccine expired on 4th June 2022. No symptoms reported. The reporter consented to follow up via email. Additional Supportive Information: The patient received expired Kinrix, which led to expired vaccine used.
there was NO adverse event.  apparently I did not read a question carefully enough on the text check-ins that I signed up for - I have had NO adverse effect from the vaccine nor boosters
patient received dose from a vial that was punctured for more than 12 hours; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received dose from a vial that was punctured for more than 12 hours) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received dose from a vial that was punctured for more than 12 hours). On 04-Oct-2021, EXPIRED PRODUCT ADMINISTERED (patient received dose from a vial that was punctured for more than 12 hours) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Information has been received from a physician, via a company representative, concerning a female patient (age not specified), who on 07-OCT-2007 was vaccinated with the first dose of Gardasil (lot # not reported). On 11-OCT-2007 the patient developed lymph node swelling in her neck. On 11-DEC-2007, the patient presented to the physician's office to receive her second dose of Gardasil, and informed the physician of her symptoms. The physician confirmed that bilateral lymph node swelling was still present at the visit. It was unknown if the patient received the second dose of Gardasil. Additional information has been requested.
Headache; Neckache; tachycardia; nausea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 57-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05Apr2022 at 16:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 57 years intramuscular, in right arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for Covid-19 immunization; Covid-19 vaccine (Dose 3. , Manufacturer Unknown), for Covid-19 immunization. The following information was reported: HEADACHE (non-serious) with onset 05Apr2022 at 21:00, outcome "recovered"; NECK PAIN (non-serious) with onset 05Apr2022 at 21:00, outcome "recovered", described as "Neckache"; NAUSEA (non-serious) with onset 05Apr2022 at 21:00, outcome "recovered"; TACHYCARDIA (non-serious) with onset 05Apr2022 at 21:00, outcome "recovered". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (26May2022) Negative. Therapeutic measures were not taken as a result of headache, neck pain, tachycardia, nausea.  Additional information: Patient did not received any other vaccine in four weeks. Patient did not had covid prior vaccination. Patient has been tested for covid post vaccination.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
On 12/28 started with itchy rash on left side of body.  Arm, hand, leg, foot.  Then started on lips and inside mouth.  Did go to left arm.  Started on prednisone 12/31 prescribed by my PCP.   Using pepcid and Zyrtec as well as benadryl cream.  Have completed 5 days of 30mg prednisone and 1 day of 20mg prednisone and rash remains.  Continues to itch.  Mouth is better but left side of body no better.   Did have shot in left arm.  Have changed nothing and no new food.  Spoke to several doctors at the hospital that I work at and they are worried that it is from covid vaccine.
My left arm has hurt and been hard to move since the shot. I have trouble moving my hand and arm because it feels like someone is pulling my muscles. It is from area of shot to hand. It has become worse in last two weeks. Area near elbow is hard to move. I mentioned this to the Pharmacy several times.  Today a tech gave me this sight to make a claim. I mentioned to my doctor office and they mentioned to take ibuprofen.
Patient was admitted to the Hospital with dx of a Pulmonary Embolus 2/9/21 Above  named Hospital
Within 5 min. of receiving MMR and Typhoid said he wasn't feeling well, passed out and had jerking episode. Did no respond to ammonia. B/P decreased revived on his own within 2-4 min. Felt weak, diaphoretic. Within 30 min. revived enough to to be driven home. B/P recovered.
This is a spontaneous report received from a contactable consumer or other non-HCP, for a Pfizer sponsored program (150559). A 76-year-old male patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), at the age of 76, Mar 2021, single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. The patient's international normalised ratio increased (elevated INR), onset 2021, with outcome of unknown. Relevant laboratory tests and procedures available in the appropriate section. Additional information: Patient reported having the COVID-19 vaccine back in Mar 2021. After first vaccination patient reported elevated INR. Follow-up (Nov 19, 2021): This follow-up submitted to notify that the batch/lot number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information expected.
pt reported feeling flushed, lightheaded and "feeling heavy". symptoms resolved after 15 minutes
Rapid Heart Beat above 90 bpm began 11 hours after covid-19 vaccine. Rapid heart beat was constant for just over eight hours. Could not sleep that night because of this. Fever was 101° stuffed up nose, swollen tonsils  and extream body aches with joint pain lasted 24 hours.
Increasing pain at injection site. Swollen, painful lymph node 2.5 inches from arm pit on the same arm as injection site.
This spontaneous report was received from a registered pharmacist via a company representative concerning a female patient of unknown age. On 09-MAY-2013, the patient was vaccinated with a dose of ZOSTAVAX (lot number and expiry date reported as J000436 and 10-APR-2014 respectively, dose and route unspecified). No concomitant medications were reported. On 19-MAY-2013, the patient experienced hives under their arms, under their breasts, and around their groin area after receiving the vaccination. The patient went to an unspecified hospital for an emergency room visit on two different unspecified days. It was unsure if the patient was admitted to the unspecified hospital on the two different unspecified days. The patient sought medical attention (contacted pharmacist by phone). It was unspecified if any treatment was given. The outcome of the event was unknown. The relatedness for the event was unknown for ZOSTAVAX. Additional information has been requested.
Client stated, "I felt dizzy when I started walking to observation room." Vaccinating RN was walking with client from vaccination station to observation room and helped guide patient into a chair. Co Lead RN assessed client to be unable to walk to observation room. Co Lead RN went to bring wheelchair for client and helped transfer client with two nurse standby assist into wheelchair. Client was then transferred from wheelchair into the gravity chair in observation room. At 11:50 AM first vitals taken by observation nurse RN: BP LA 120/79, pulse 68, 110%. Observation RN advised client to take long deep breaths and relax. Client already had water bottle provided but declined crackers. Client stated, "I was just really nervous about the covid shot. It took me a year to finally do it." 11:55 AM second vitals taken: BP LA 126/80 pulse 94 O2 SAT 100%, respirations 18. Client stated, "I had to really try hard to catch my breath. I have a lot of anxiety to the shot. My left hand is tingling." Co Lead RN asked client if they were having trouble swallowing to which client denied having such symptoms. Co Lead RN observed client's left arm for swelling or hives to which none were observed. Client denied having any itching throughout entire body. Co Lead RN advised client to continue taking long deep breaths. Client does not have any medical conditions and does not take any medications. 12:00 PM next set of vitals: BP RA 129/81, pulse 66, O2SAT 100%. Client stated, "I am breathing better." 12:03 PM client notified her mom via cellphone but she was at work, then client called cousin who was at school. Client stated at 12:05 PM "all my symptoms are gone" and was observed to be A&Ox4. At 12:15 PM last vitals: BP LA 120/86 PULSE 69, O2 SAT 99%. Co Lead RN recommended for client to follow up with PCP within 24 hours, enroll in VSAFE, and the adverse symptoms to call 911 or go to emergency room. At 12:25 client left facility with steady gait as Co Lead RN walked standby assist along side client towards the exit of the facility.
Pt experienced fever of 102 degrees 5 hrs after injections with chills, body aches, intermittent nausea & vomiting cannot eat.
3 days site of vax sore, red, throbbing;low grade fever, lethargy/irritability, felt flushed told by nurse to take ex-strength APAP & use warm soaks on rt arm;